Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase EARLY_PHASE1 7Phase NA 5Phase 3 4Phase 1/2 4Phase 1 4Phase 4 3

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Plasma cell 1

Conditions

Tuberous Sclerosis 1Pancreatic Neoplasms 1Multiple Myeloma 1Lymphangioleiomyomatosis 1Advanced Biliary Tract Carcinoma 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Simvastatin × Clear all
NCT07392541 2026-03-23

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Tongji Hospital

Phase 1/2 Recruiting
29 enrolled
Gastrointestinal

Advanced Biliary Tract Carcinoma

NCT06030622 2024-04-19

C3

State University of New York - Downstate Medical Center

Phase 1/2 Unknown
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed
10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00281476 2011-11-01

The Effect of High Dose Simvastatine on Multiple Myeloma

Vejle Hospital

Phase 1/2 Completed
10 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡